RedHill Biopharma Ltd. (RDHL) Form 6-K — Jun 18, 2026
RedHill Biopharma Ltd. announced a definitive agreement for a private placement to sell 8,571,429 American Depositary Shares and accompanying warrants at a purchase price of $0.70 per ADS. The transaction is expected to generate immediate gross proceeds of approximately $6 million, with the potential for an additional $13.4 million if the warrants are exercised in full.
Key figures
- Gross Proceeds
- $6 million
- Offering Price
- 0.7
- Shares Offered
- 8571429
- Series A1 Warrant Term
- 5 years
- Series A2 Warrant Term
- 18 months
- Total Potential Proceeds
- $19.4 million
- Potential Warrant Proceeds
- $13.4 million
- Series A1 Warrant Exercise Price
- $0.86
- Series A2 Warrant Exercise Price
- $0.70
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.